首页> 外文期刊>Research and practice in thrombosis and haemostasis. >COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
【24h】

COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance

机译:Covid-19相关的凝血病和血栓栓塞疾病:临时专家指导评论

获取原文
       

摘要

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)is the causative pathogen of a new infectious disease, coronavirusdisease 2019 (COVID-19), that first occurred in late December 2019in the city of Wuhan in Hubei Province, China. It has since spreadglobally, resulting in a World Health Organization (WHO) declaredpandemic, with as yet (April 28, 2020) 3 million confirmed casesand 200 000 confirmed deaths. As for every new disease, clinicians,hospitals, and governments struggle to find optimal clinicaland public health measures to contain its spread and burden. Forthis, information from scientific research is crucial, and fortunatelywe see a rapidly accumulating output of studies. However, keepingup with the increasing output and its content and quality is a challengefor everyone involved in this outbreak, especially those at thefront lines of patient care. Scientific journals and societies can playan important role in summarizing and channeling the data, and reviewarticles are a great help.
机译:严重的急性呼吸综合征冠状病毒2(SARS-COV-2)是新型传染病,冠状病毒2019(Covid-19)的致病病原体,该疾病2019年(Covid-19)首次发生在2019年12月底,湖北省武汉市。自扩张以来,它已达到澳大利亚,导致世界卫生组织(世卫组织)宣布为宣布,尚未(4月28日,2020年)> 300万确认案件> 200 000确认死亡。至于每种新疾病,临床医生,医院和政府都在努力寻找最佳的临床和公共卫生措施,以遏制其传播和负担。从科学研究的信息至关重要,幸运的是我们可以快速积累的研究。然而,随着产出的增加及其内容和质量,对所有参与这种爆发的挑战,特别是那些在患者护理的周边行。科学期刊和社会可以在总结和介绍数据方面玩重要作用,以及综合性是一个很大的帮助。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号